Five Things Going Right: September 9, 2026

Five real advances in science, medicine, technology, and the environment, each verified against the original reporting. In this episode: A new pancreatic cancer drug has doubled lifespan for late-stage patients and received immediate FDA approval; A new method (S-DEIM) estimates sea surface temperatures 40% more accurately than conventional approaches and; Researchers from Kyoto University developed a rational method for designing defined microbial communities; A decade-long randomized trial found that implantable cardioverter-defibrillators may benefit patients under; A study of 25 Black women found that racialized bias in childhood classrooms has lasting negative effects on.

Stan Berteloot is a French-American journalist, marketing strategist, and AI expert based in Princeton, New Jersey. A University of Maryland journalism graduate, he navigates the intersection of storytelling, technology, and culture. As Head of Strategy and CTO at Nytro Marketing, he pioneered AI-driven content creation, launching the AI in Marketing podcast. He also hosts Back in America, a podcast exploring American identity through in-depth conversations on race, misinformation, and AI ethics. Start your VoiceStream free trial today!

📚 Sources:

• https://www.goodnewsnetwork.org/fda-immediately-approves-drug-thats-doubling-lifespan-for-late-pancreatic-cancer-patients/
• https://phys.org/news/2026-09-sparse-method-sea-surface-temperatures.html
• https://phys.org/news/2026-09-optimizing-tomato-growth-microbes.html
• https://scitechdaily.com/cardiac-breakthrough-could-offer-lifesaving-treatment-to-more-patients/
• https://phys.org/news/2026-09-classrooms-careers-black-women-effects.html

What is Five Things Going Right?

Five Things Going Right is a daily five-minute podcast covering real, verifiable progress in science, medicine, technology, and the environment. Every weekday, hosts Grace and Josh walk through five stories that actually happened, each checked against the original reporting from sources like the WHO, the IEA, Nature, and university research. A calm, fact-grounded start to your day. New episodes every weekday morning.

Welcome, this is 5 Things Going Right, the news that's actually good. Five stories, five minutes, all of them true. Hi everyone, I'm Grace. And I'm Josh. Today is Wednesday, September 9th, 2026. Here's what we're covering today. Let's start with some promising news in the medical field. A new drug has been developed for pancreatic cancer patients. It's a two-a-day pill that is shown to roughly double the survival time for those with late-stage pancreatic cancer, even for patients where chemotherapy has failed. That's right. Grace, the Food and Drug Administration has already given its approval for this drug. Although pancreatic cancer has a notoriously poor outlook, with only about 3% of patients surviving more than 5 years, this new drug marks an improvement. However, it's important to note that even doubling survival time still means less than two years for most patients. Environmental research. Scientists at North Carolina State University have developed a new method called S-DEIM. This method extrapolates sea surface temperatures from sparse data and is about 40% more accurate than commonly used computational methods. And it's slightly more accurate than the best-performing artificial intelligence models, too. What's impressive is that it takes a fraction of the time to train. This advancement has significant implications for both short-term weather forecasting and long-term climate prediction. In agricultural news, researchers at Kyoto University have been working on a method to support tomato plant growth under climate stress. They've combined nine types of bacteria with two types of plant metabolites to build defined microbial communities. The goal here is to help plants absorb nutrients better and increase their resistance to disease, drought, and heat. This study was conducted in a laboratory setting, so while the results are promising, they haven't yet been tested in real field conditions, where environmental factors vary. Now, let's talk about a potential shift in cardiac treatment. A randomized trial led by Flinders University has been running for over a decade and suggests that implantable cardioverter defibrillators could benefit patients younger than 70 with cardiac scarring and mild to moderate heart function loss. This is interesting because this group isn't currently included in standard treatment guidelines. The findings indicate that these devices could help patients who were not previously considered clear candidates for such treatment. Finally, a study from the University of Utah has shed light on the long-term effects of racialized bias in classrooms on Black women. The study involved interviews with 25 Black women who shared their experiences. The participants reported lasting impacts on their career paths and mental health, even those who went on to earn advanced degrees. One participant recalled a teacher questioning her success in advanced mathematics because of a stereotype that Black girls aren't good at math, which influenced her career choices. That's all for today's stories. It's clear that these developments, whether in medicine, environment, agriculture, or social sciences, have significant implications. Thanks for tuning in. We'll be back with more updates soon. That's it for today. That was 5 Things Going Right. Come back tomorrow for five more.